A modern view of the place of b-blockers in the treatmentof cardiovascular disease: the choice of drug within a class is crucial | Zendy

О. Д. Остроумова | Zendy; В. М. Фомина | Zendy; Е. А. Smolyarchuk | Zendy

Open Access

A modern view of the place of b-blockers in the treatmentof cardiovascular disease: the choice of drug within a class is crucial

Author(s) -

О. Д. Остроумова,

В. М. Фомина,

Е. А. Smolyarchuk

Publication year - 2015

Publication title -

systemic hypertension

Language(s) - English

Resource type - Journals

eISSN - 2542-2189

pISSN - 2075-082X

DOI - 10.26442/sg29128

Subject(s) - medicine , drug , heart failure , coronary heart disease , drug class , metoprolol , disease , cardiology , selection (genetic algorithm) , coronary artery disease , intensive care medicine , pharmacology , computer science , artificial intelligence

In the article discusses questions of application of b-blockers (b-AB) for the treatment of arterial hypertension, coronary heart disease, chronic heart failure. The data from modern Russian and European recommendations about the place of b-AB in the treatment of cardiovascular diseases. Analyzed in detail the selection of b-AB inside the class from the standpoint of pharmacokinetics, selectivity, study in clinical studies. Data about efficiency and safety of application of metoprolol succinate for the treatment of arterial hypertension, coronary heart disease, chronic heart failure.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research